PEPTIDE Registry

Reported experiences and published evidence, kept separate. Explore what people seek, what sources actually study and what remains unknown.

Collection closed. No participant results published.

What would you like to explore?

All groups and topics

Reported-use topics, not evidence grades or diagnoses. The catalog does not cover every possible experience.

AOD-9604

Editorial context from existing sources; independent scientific review pending. Numerical findings held. A reported-use topic does not establish direct evidence for that aim.

The FDA review describes Tyr-hGH(177–191) and unsuccessful obesity evidence, including a large randomized study. The clinical findings should remain visible beside the mechanism.

Food-use GRAS context does not constitute injectable drug approval. Oral-study results cannot establish the effectiveness or safety of a different injected regimen.

Sources and proposed-mechanism explanation

The proposed rationale derives from a modified growth-hormone fragment. hCG and hGH are different hormones; a similar fragment label cannot settle molecular identity.

FDA: AOD-9604 evaluation, December 2024 (new tab)

Practice & Evidence: claims and limits Atlas: molecule science

Collection, review and methods

8 documents · 24 educational profiles · 10 guides. Hosting authorization and reviews remain pending. Drafts are not reports; they do not establish effectiveness or safety.

Methods, consent and privacy

Understanding community practices What each evidence label means Stacks, mixtures and claims of synergy How we handle reported doses and cycles Reading a peptide quality report When someone says it worked Source errors, corrections and retractions From experience to a research question The proposed Community Observation Program Reading future observational results